Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Feasibility Trial of Post-Transplant Infusion of Allogeneic Regulatory T Cells and Allogeneic Conventional T Cells in Patients With Hematologic Malignancies Undergoing Allogeneic Myeloablative Hematopoietic Cell Transplantation From Haploidentical-Related Donors

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT01050764
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:36:53.379736+00:00
Published At
2017-05-11T00:00:00+00:00
Record Updated At
2018-06-27
Results Posted At
2017-05-11
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Leukemia, Acute", "Chronic Myelogenous Leukemia (CML)", "Myelodysplastic Syndrome (MDS)", "Non-Hodgkin Lymphoma (NHL)", "Chronic Lymphocytic Leukemia (CLL)", "Acute Myelogenous Leukemia (AML)", "Acute Lymphoblastic Leukemia (ALL)"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2018-06-27"
protocolSection.identificationModule.nctId
"NCT01050764"
protocolSection.identificationModule.officialTitle
"A Feasibility Trial of Post-Transplant Infusion of Allogeneic Regulatory T Cells and Allogeneic Conventional T Cells in Patients With Hematologic Malignancies Undergoing Allogeneic Myeloablative Hematopoietic Cell Transplantation From Haploidentical-Related Donors"
protocolSection.statusModule.overallStatus
"TERMINATED"
protocolSection.designModule.phases
["PHASE1", "PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2017-05-11"

Study condition terms

  • Leukemia, Acute (protocolSection.conditionsModule.conditions)
  • Chronic Myelogenous Leukemia (CML) (protocolSection.conditionsModule.conditions)
  • Myelodysplastic Syndrome (MDS) (protocolSection.conditionsModule.conditions)
  • Non-Hodgkin Lymphoma (NHL) (protocolSection.conditionsModule.conditions)
  • Chronic Lymphocytic Leukemia (CLL) (protocolSection.conditionsModule.conditions)
  • Acute Myelogenous Leukemia (AML) (protocolSection.conditionsModule.conditions)
  • Acute Lymphoblastic Leukemia (ALL) (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.